These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 20184423

  • 1. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
    de Villiers TJ.
    Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423
    [Abstract] [Full Text] [Related]

  • 2. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis.
    Kung AW, Chu EY, Xu L.
    Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bazedoxifene: a new selective estrogen receptor modulator for postmenopausal osteoporosis.
    Genant HK.
    Menopause Int; 2011 Jun; 17(2):44-9. PubMed ID: 21693498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.
    Silverman SL, Chines AA, Kendler DL, Kung AW, Teglbjærg CS, Felsenberg D, Mairon N, Constantine GD, Adachi JD, Bazedoxifene Study Group.
    Osteoporos Int; 2012 Jan; 23(1):351-63. PubMed ID: 21779819
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.
    Kanis JA, Johansson H, Oden A, McCloskey EV.
    Bone; 2009 Jun; 44(6):1049-54. PubMed ID: 19254788
    [Abstract] [Full Text] [Related]

  • 15. Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
    Drugs R D; 2008 Jun; 9(3):191-6. PubMed ID: 18457472
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS, Mirkin S, Jenkins SN.
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [Abstract] [Full Text] [Related]

  • 18. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.
    Smith CL, Santen RJ, Komm B, Mirkin S.
    Breast Cancer Res; 2014 Jun 18; 16(3):212. PubMed ID: 25928299
    [Abstract] [Full Text] [Related]

  • 19. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH, Komm BS.
    Post Reprod Health; 2015 Sep 18; 21(3):112-21. PubMed ID: 26289836
    [Abstract] [Full Text] [Related]

  • 20. [Selective estrogen receptor modulators (SERMs)].
    Chaki O.
    Nihon Rinsho; 2015 Oct 18; 73(10):1673-81. PubMed ID: 26529929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.